Graham Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,444
Closed -$195K 1457
2026
Q1
$195K Buy
25,444
+11,087
+77% +$84.8K ﹤0.01% 959
2025
Q4
$140K Sell
14,357
-30,340
-68% -$258K ﹤0.01% 1111
2025
Q3
$187K Buy
+44,697
New +$286K ﹤0.01% 1073
2025
Q2
Sell
-38,118
Closed -$372K 1566
2025
Q1
$372K Buy
38,118
+7,938
+26% +$98.2K 0.01% 918
2024
Q4
$365K Buy
30,180
+1,731
+6% +$21K 0.01% 852
2024
Q3
$312K Buy
28,449
+5,824
+26% +$59.2K 0.01% 768
2024
Q2
$204K Sell
22,625
-68,512
-75% -$478K ﹤0.01% 861
2024
Q1
$745K Buy
91,137
+40,962
+82% +$336K 0.01% 505
2023
Q4
$423K Buy
50,175
+30,308
+153% +$351K 0.01% 638
2023
Q3
$340K Buy
+19,867
New +$390K 0.01% 682
2022
Q2
Sell
-21,200
Closed -$359K 1204
2022
Q1
$359K Buy
+21,200
New +$400K 0.01% 669

Other funds holding REPL

Graham Capital Management's REPL Position: Q2 2026 in Review

Graham Capital Management sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 25,444 shares — an estimated $195K sold.

Graham Capital Management first reported a position in REPL in Q1 2022 and held it in 11 quarters. The position peaked at $745K in Q1 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Graham Capital Management reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 25,444 Replimune Group shares in Q2 2026, an estimated $195K.
  • Graham Capital Management first reported a position in Replimune Group in Q1 2022 and held it in 11 quarters.
  • Graham Capital Management's Replimune Group position peaked at $745K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.